Stable F&E Budgets help Biotech Suppliers Defy the Crisis
Weaknesses in product development and high research costs for pharmaceutical companies provide opportunities for biotech companies
18-Jun-2009 -
Several American pharmaceutical giants such as Pfizer, Johnson & Johnson or Merck & Co are currently fighting losses in sales and a lack of upcoming products. In Europe, Sanofi-Aventis and GlaxoSmithKline are affected. However, not all pharmaceutical companies are suffering from the crisis. ...
Bayer
biotechnology
Germany
+9